Child Welfare Subsidy Percentage Reduction

Colorado HB1373 reduces monthly subsidy reimbursement percentages for child welfare services provider contracts. The bill was signed by Governor on April 2, 2026, and includes a reduced appropriation for affected programs. Child welfare service providers in Colorado should prepare for decreased reimbursement rates under new contracts.

Repeals Medicaid Reimbursement for Equine Therapy

Colorado Governor signed HB1365 into law on April 2, 2026, eliminating Medicaid reimbursement for therapy using equine movement. The bill, sponsored by bipartisan legislators, also reduces the associated state appropriation. Healthcare providers offering equine therapy to Medicaid patients will no longer receive state reimbursement for these services.

Somerset Therapeutics Dexamethasone Injection Class II Recall

The FDA issued a Class II recall for Somerset Therapeutics LLC's Dexamethasone Sodium Phosphate Injection (100mg/10mL, 10x10mL vials) after stability testing at product expiry (24 months) revealed out-of-specification impurity levels. The affected impurities are Dexamethasone Sodium Phosphate EP Impurity G and dexamethasone formate. The recall is ongoing and affects nationwide distribution in the USA.

Teva Pharmaceuticals Octreotide Acetate Class II Sterility Recall

The FDA announced a Class II recall of Teva Pharmaceuticals' Octreotide Acetate for Injectable Suspension 10mg single-dose vials due to lack of sterility assurance. Quality system deficiencies were identified at the contract manufacturer Pharmathen International S.A. in Greece during a routine FDA inspection. The recall affects products distributed nationwide in the USA and is currently ongoing.

CUROSURF Sterility Recall - Chiesi USA

FDA announced Class II recall D-0402-2026 for CUROSURF (poractant alfa) 240mg Intratracheal Suspension by Chiesi USA, Inc. The recall was initiated due to lack of assurance of sterility. The affected product (NDC 10122-510-03) was distributed nationwide within the United States, and the recall is currently ongoing.

Apotex Brimonidine/Timolol Ophthalmic Solution Class II Recall

The FDA announced a Class II recall of Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution 0.2%/0.5% manufactured by Apotex Corp. The recall (Case No. D-0407-2026) was initiated due to lack of assurance of sterility. The affected product has NDC 60505-0589-1 and was distributed nationwide in the U.S.

Amerisource Meclizine Recall - Failed Tablet Specifications

Amerisource Health Services LLC, distributed by American Health Packaging, initiated a Class II recall of Meclizine Hydrochloride Tablets, USP 12.5 mg nationwide. The recall (D-0418-2026) was initiated due to failed tablet specifications affecting products with NDC codes 60687-775-65 and 60687-775-11. The recall is ongoing with no specific return deadline provided.

Octreotide Acetate 20mg Class II Sterility Recall

FDA classified a Class II recall for Teva Pharmaceuticals USA's Octreotide Acetate 20mg injectable suspension (NDC 0071-4185-25) due to lack of sterility assurance. The recall stems from quality system deficiencies identified at the contract manufacturer Pharmathen International S.A. in Greece during a routine FDA inspection. The affected product was distributed nationwide in the USA.

Levothyroxine 150 mcg, Class II recall

FDA announced a Class II recall of Levothyroxine Sodium Tablets USP 150 mcg (1000 tablet bottles) manufactured by Macleods Pharmaceuticals Ltd. for Macleods Pharma USA, Inc. The recall was initiated due to subpotent drug concerns. The recall is ongoing with nationwide distribution.

Octreotide Acetate 30mg Class II Recall - Sterility Concerns

FDA issued a Class II drug recall for Octreotide Acetate for Injectable Suspension 30mg single-dose vials distributed by Teva Pharmaceuticals USA, Inc. The recall was initiated due to lack of assurance of sterility stemming from quality system deficiencies identified during an FDA inspection at the contract manufacturer Pharmathen International S.A. in Greece. The recalled product was distributed nationwide in the United States.